Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosis.
Bethoux FA, Farrell R, Checketts D, Sahr N, Berwaerts J, Alexander JK, Skobieranda F. Bethoux FA, et al. Among authors: berwaerts j. Mult Scler Relat Disord. 2024 Sep;89:105740. doi: 10.1016/j.msard.2024.105740. Epub 2024 Jun 20. Mult Scler Relat Disord. 2024. PMID: 39106541 Free article. Clinical Trial.
Development of an integrated conceptual model of multiple sclerosis spasticity.
Cameron MH, Bethoux F, Field-Fote E, Lenderking WR, Zaiser E, Cutts KN, Wagner JM, Berwaerts J, Steinerman JR. Cameron MH, et al. Among authors: berwaerts j. Disabil Rehabil. 2024 Jun;46(13):2955-2965. doi: 10.1080/09638288.2023.2237403. Epub 2023 Jul 22. Disabil Rehabil. 2024. PMID: 37480330 Review.
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Nicholas J, Lublin F, Klineova S, Berwaerts J, Chinnapongse R, Checketts D, Javaid S, Steinerman JR. Nicholas J, et al. Among authors: berwaerts j. Mult Scler Relat Disord. 2023 Jul;75:104745. doi: 10.1016/j.msard.2023.104745. Epub 2023 May 1. Mult Scler Relat Disord. 2023. PMID: 37209500 Free article. Clinical Trial.
Metabolism and disposition of JNJ-10450232 (NTM-006) in rats, dogs, monkeys and humans.
Lim HK, Chen J, Lam W, Gong Y, Leclercq L, Silva J, Salter R, Berwaerts J, Gelotte CK, Vakil AM, Eichenbaum GE, Kuffner EK, Flores CM. Lim HK, et al. Among authors: berwaerts j. Regul Toxicol Pharmacol. 2023 Mar 16:105379. doi: 10.1016/j.yrtph.2023.105379. Online ahead of print. Regul Toxicol Pharmacol. 2023. PMID: 36931586 Free article.
First-in-human study to evaluate the safety, tolerability and pharmacokinetics of a novel analgesic and antipyretic drug with structural similarity to acetaminophen.
Gelotte CK, Vakil AM, Berwaerts J, Zimmerman BA, Eichenbaum GE, Flores CM, Kuffner EK. Gelotte CK, et al. Among authors: berwaerts j. Regul Toxicol Pharmacol. 2022 Oct;134:105236. doi: 10.1016/j.yrtph.2022.105236. Epub 2022 Aug 5. Regul Toxicol Pharmacol. 2022. PMID: 35934140 Clinical Trial.
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia.
Rossenu S, Cleton A, Hough D, Crauwels H, Vandebosch A, Berwaerts J, Eerdekens M, Herben V, De Meulder M, Remmerie B, Francetic I. Rossenu S, et al. Among authors: berwaerts j. Clin Pharmacol Drug Dev. 2015 Jul;4(4):270-8. doi: 10.1002/cpdd.144. Epub 2014 Aug 28. Clin Pharmacol Drug Dev. 2015. PMID: 27136907 Clinical Trial.
45 results